Skip to main content
. 2024 Oct 7;8(10):e70007. doi: 10.1002/hem3.70007

Figure 1.

Figure 1

CAR T manufacturing data. (A) Transduction efficiency of ssCART‐19 group and cCART‐19 group (p = 0.313; t‐test). (B) CD4+/CD8+ T‐cell ratio of ssCART‐19 and cCART‐19 group (p = 0.440; t‐test). (C) Cytotoxicity of ssCART‐19 and cCART‐19 groups against target cells (p = 0.364; t‐test).